Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Aseptic Process Simulation (Media Fill)

Posted on By

SOP for Aseptic Process Simulation (Media Fill)

Procedure for Aseptic Process Simulation (Media Fill)

1) Purpose

The purpose of this SOP is to outline the procedure for conducting aseptic process simulations (media fills) to validate the aseptic manufacturing process.

2) Scope

This SOP applies to all aseptic manufacturing processes within the facility that require validation through media fill simulations, following regulatory guidelines and internal specifications.

3) Responsibilities

Quality Assurance (QA) Department: Responsible for overseeing and approving media fill activities.
Production Department: Responsible for executing media fills according to validated procedures and maintaining aseptic conditions.

4) Procedure

4.1 Media Preparation:
    4.1.1 Prepare growth media according to specified formulation and sterilization procedures.
    4.1.2 Sterilize media using validated sterilization methods (e.g., autoclaving) and aseptic techniques.

See also  SOP for Angle of Repose Testing

4.2 Filling Process:
    4.2.1 Set up the filling line or equipment in accordance with routine production conditions.
    4.2.2 Fill containers (e.g., vials, ampoules) with sterile growth media under aseptic conditions.
    4.2.3 Seal containers using appropriate closures and labeling as per procedure.

4.3 Incubation:
    4.3.1 Place filled containers in the incubator under conditions that promote microbial growth.
    4.3.2 Incubate containers for the specified time period required for microbial recovery.

4.4 Inspection and Evaluation:
    4.4.1 Inspect containers for any signs of microbial growth or contamination.
    4.4.2 Record and document observations, including any

deviations from expected results.
    4.4.3 Evaluate media fill results against predefined acceptance criteria.

See also  In-Process Control: SOP for Blend Uniformity Testing

4.5 Documentation and Report:
    4.5.1 Compile all data, results, and observations into a Media Fill Report.
    4.5.2 Include detailed records of media preparation, filling process, incubation conditions, and evaluation criteria.
    4.5.3 Obtain QA approval for the media fill report before implementation in routine production.

5) Abbreviations, if any

QA: Quality Assurance

6) Documents, if any

Media Fill Protocol
Media Fill Report
Media Preparation Records
Incubation Records

7) Reference, if any

FDA Guidance for Industry – Sterile Drug Products Produced by Aseptic Processing
Pharmacopeial standards for media fill simulations

8) SOP Version

Version 1.0

In-Process Control Tags:Blend uniformity testing SOP, Bulk density testing SOP, Capsule content uniformity SOP, Capsule disintegration testing SOP, Capsule dissolution testing SOP, Capsule weight variation SOP, Clarity and opalescence testing of liquids SOP, Endotoxin testing in injectable products SOP, Flowability testing of powders SOP, Granulation size distribution SOP, Moisture content determination in granules SOP, Osmolality testing SOP, Particulate matter testing in liquids SOP, pH measurement of solutions SOP, Pyrogen testing SOP, Specific gravity testing of liquids SOP, Sterility testing SOP, Tablet disintegration testing SOP, Tablet dissolution testing SOP, Tablet friability testing SOP, Tablet hardness testing SOP, Tablet thickness measurement SOP, Tablet weight variation SOP, Uniformity of dosage units SOP, Viscosity testing of liquids SOP

Post navigation

Previous Post: SOP for Terminal Sterilization Validation
Next Post: SOP for Quality Assurance Audits

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version